Insider trade

Officer sold ~$143K of HALO shares in the open market

Traded Mar 9, 2026 · Filed Mar 10, 2026

Why it stands out

Halozyme's SVP, CHIEF OPERATING OFFICER sold $143K of Halozyme shares. Nobody planned it ahead of time.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Officer$100K–$500K

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$143,329

Shares × reported transaction price

Timing vs results

20 days after results of Feb 17, 2026, 63 days before results of May 11, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

After	Stock	S&P 500	Difference
7 days	−4.3%	−2.2%	−2.1%
30 days	+2.0%	+0.5%	+1.6%
90 days	+7.5%	+9.0%	−1.5%
180 days	+62.9%	+13.3%	+49.7%

Past results only. Not a forecast.

Represents a weighted average sales price per share. The shares were sold at prices ranging from $68.210 to $68.320. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

6mo ago

Derivative exercise or conversion — not an open-market buy.

Scheduled in advance6mo ago

Scheduled in advance6mo ago